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The fatty acids of cerebrosides, sphingomyelins, phosphatidyl cholines and phosphatidyl ethanolamines from 4 different regions of 6
human brains with alcoholic "hepatocerebral degeneration" were examined and compared with those from 6 normal brains. — A sig-
nificant or slight decrease of long chain fatty acids in the cerebrosides, sphingomyelins and phosphatidyl cthanolamins was found in the
grey matter of the cortex. These changes were interpreted as indicating a typical degenerative process. In the areas of white matter a
lengthening of the C-chain of fatty acids in cerebrosides and sphingomyelins was noted as well as an increase of the polyenoic acids in the
phosphatidyl ethanolamines. These changes are considered to indicate an atypical type of degeneration. Similar changes in other diseases
of the brain have not yet been described. — The chemical changes did not correlate with the histology, the changes of which were very
slight, but they did parallel the clinical picture, as all abnormal brains were derived from patients with hepatic failure and advanced neu-
rological and mental symptoms.
Untersucht wurden die Fettsäuren der Cerebroside, Sphingomyeline, Phosphatidylcholine und Phosphatidyläthanolamine aus 4 ver-
schiedenen Regionen 6 menschlicher Gehirne mit alkohol-toxischer „hepatocerebraler Degeneration" (hepatoportale Encephalopathie)
und 6 Normalgehirnen. — In der grauen Substanz des Cortex findet man eine signifikante oder geringe Abnahme der langkettigen Fett-
säuren der Cerebroside, Sphingomyeline und Phosphatidyläthanolamine. Diese Veränderungen gegenüber gesunden Gehirnen werden als
typische degenerative Erscheinungen interpretiert. In den mark-reichen Regionen finden sich neben typischen degenerativen Erschei-
nungen auch Verlängerungen der C-Kette der Fettsäuren in den Cerebrosiden und Sphingomyelinen und eine Zunahme der Polyensäuren
in den Phosphatidyläthanolaminen. Diese Veränderungen werden als atypische Form der cerebralen Degeneration bezeichnet. Änderungen
in der vorliegenden Art sind für andere Erkrankungen des Gehirnes bisher nicht beschrieben worden. — Die chemischen Veränderungen
in den untersuchten Gehirnen korrelieren nicht mit dem Grad der histologischen Veränderungen, welche sehr gering sind. Es besteht
jedoch eine gewisse Parallele zum klinischen Bild: alle untersuchten Patienten mit Hepatargie hatten ausgeprägte neurologische und
psychische Symptome.
The brain lipids of patients who had died as a result
of alcoholic cirrhosis showed distinct deviations from
those in normal brains (1—3). The decrease of the
cerebrosides in all regions examined and the decline of
the glycerophosphatides and cholesterol in the regions
rich in white matter was conspicuous. Due to lack of
information on the fatt}r acid composition of these
lipids in "hepatocerebral degeneration", we extended
the examination to this field.
Material and Methods
Autopsy
The autopsies were performed within 24 to 48 hrs after death. All
the material of the normal human brains was subjected to
pathological-anatomical examinations and quantitative analysis of
the main lipids. These were isolated only from material that
showed no pathological changes. The brains examined of patients
who died as a result of cirrhosis showed some macroscopic and
microscopic changes, which have been described previously (3).
The brains were generally removed -within 24 to 48 hrs after death
(4, 5), mainly because of legal problems. In several experiments
we could show that within the first two days after death no
changes occur in the lipids (LESCH, unpublished). The cerebrosides
are also unchanged under autolytic conditions within 24 days
post mortem (6).
Degenerated brains
The fatty acids of cerebrosides, sphingomyelins, phosphatidyl
cholines and phosphatidyl ethanolamines of brains from patients
aged 38—58 years who had died as a result of alcoholic cirrhosis
were examined. The patients had a 2 to 10 years history of ex-
cessive alcohol consumption. (The intake of 2 patients estimated
at between 700 and 1500 kg of pure ethanol, and not less than
500 kg pure alcohol respectively.) Concerning the stationary
treatment and clinical complications, see (3).
Normal brains
The fatty acids of the same major lipids of 6 normal brains from
people aged between 50 and 80 years were examined. Their re-
sults have been published previously (7—9) and serve as a com-
parison with the present examination.
Brain regions
Within 48 hrs of death 20—50 g of fresh tissue was taken from the
following regions of the 6 brains, deep frozen, and kept at —15°C
to —25°C until isolation and separation of the lipids:
grey matter (cortex) of cerebrum,
white matter of cerebrum,
cerebellum (grey and white matter mixed),
medulla oblongata (and parts of pons).
Lipids
The isolation of total lipids and the separation of the individual
lipids of normal and pathological brains was done in identical
ways, with the same type of lipid separation columns and with the
same organic solvents as are described in detail in previous
publications (3, 9, 10).
Fatty acids
The fatty acid methyl esters of the pure cerebrosides, sphingo-
myelins and phosphatidyl ethanolamines were obtained through
hydrolysis with 10% sulphuric acid in methanol (10 ml + 90 ml).
Each pure lipid, ca. 50 mg, was hydrolyzed with 5 ml of 10%
Z. Klin. Chem. Klin. Biocbem. / 11. Jahrg. 1973 / Heft 4
160 Lesch, Schmidt and Schmidt: Fatty acids in hepatocerebral degeneration
H2SO4 in methanol in a sealed tube for 5 hrs in a boiling water
bath. The tube was cooled to room temperature and opened, and
the fatty acid methyl esters of phosphatidyl ethanolamines and
sphingomyelins were extracted in the tube with 3 times 15 ml of
petrol ether (b. p. 50—70°C) and the methyl esters of cerebrosides
were extracted with 2 times 15 ml of petrol ether and 2 times 20 ml
of 'diethyl ether. The combined extracts were rinsed with water,
and than dried over anhydrous Na2SO4 overnight. The ether
solutions were evacuated over an evaporator next day. Sub-
sequently the tubes were placed over P2O5 in a dark vacuum
desiccator and kept overnight again. During evaporation we
gassed permanently and during evacuation we gassed several
times with nitrogen prior to final evacuation. But several tests
showed no decrease in values for polyenoic acids of phosphatidyl
ethanolamines when the nitrogen gassing was omitted.
The fatty acid methyl esters of phosphatidyl cholines were ob-
tained through mild alkaline methanolysis (11). To the tubes
containing phosphatidyl cholines and sphingomyelins were added
0.22ml 0.5mol/l CH3ONa in dry methanol and 1.85ml dry
chloroform: dry methanol 1:1 per 10 mg lipid. The tubes were
kept for 15 hrs at room temperature. Subsequently to each 2.1 ml
lipid methoxide fraction 1.35 ml dry chloroform was added. The
solution was placed on a silica gel column (7.5 g silica gel type
7734 E. Merck AG Darmstadt, Germany, for each 50 mg lipid).
The fatty acid methyl esters of phosphatidyl cholines could be
separated promptly from the unchanged sphingomyelins with
200ml chloroform: methanol 2:1, whereas the latter were eluted
with methanol (3). The chloroform:methanol solution was
evaporated to dryness under a gentle stream of nitrogen. Owing
to the contamination of this fraction containing the esters of
phosphatidyl cholines we used another silica gel column (10 g
type 7734 for 100—200 mg esters) and eluted the pure methyl
esters with a solution of petrol ether (b. p. 50—70°C): diethyl
ether 1:1. The latter extract was evaporated to dryness on a
water bath at 30°C under a gentle stream of nitrogen. These
tubes were also placed over P2O5 in a vacuum desiccator which
\vas promptly evacuated and kept overnight. ^
The sphingomyelins were purified as published previously (3).
The fatty acid methyl esters of phosphatidyl cholines, phos-
phatidyl ethanolamines and sphingomyelins were then ready for
analysis by gas liquid chromatography. The cerebrosides, how-
ever, had to be first separated on an activated silica gel column
into the unsubstituted and 2-monohydroxy components. Ori-
ginally this was done with the 10% AgNO3-silica gel column and
gradient elution described previously (12—14). Later we deve-
loped a simpler method, which we have not described and which,
after several tests, showed no difference of concentration of
unsubstituted and hydroxy fatty acid methyl esters of cerebrosides
of normal brains in comparison to the published method (14).
This separation method, however, contrary to the AgNO3-silica
gel column method, did not permit separation into saturated and
unsaturated fatty acids, but only into unsubstituted and substituted
acids: For 100—200 mg cerebroside fatty acid methyl esters we
used 30 g silica gel (type 7734 E. Merck AG).
Using a column of 1.6cm I. D., the unsubstituted methyl esters
were obtained by passing 300 ml ethanol-free, amylene-stabilized
chloroform (Chemische Werke H ls AG, Marl); the hydroxy
fatty acid methyl esters were then obtained by passing 200ml
dry chloroform: dry diethyl ether 10:1.
The hydroxy group of the 2-hydroxy fatty acid methyl esters were
etherified with Ag2O and CH3J on a water bath at 56°C under a
gentle stream of nitrogen over 3 hrs (15). At first 40 mg Ag2O
and 2 ml CH3J were added to 10 mg of hydroxy fatty acid mixture.
After 30 and 60 min the addition of the same amounts of silver
oxide and methyl iodide was repeated, the latter only if necessary.
• After filtration and evaporation, the methyl ethers of the methyl
esters of cerebrosides were also ready for the gas liquid chromato-
graphy.
Gas liquid chromatograpby
The methyl esters were analyzed by gas liquid chromatography in
a Perkin Elmer model 801 or 900 apparatus with flame ionization
detector. A 180 cm glass column of 3.6 mm I.D. packed with
2.5% diethylene glycol succinate polyester (DEGS) coated on
80—100 mesh Chromosorb G was used for the fatty acid methyl
esters of the two glycerophosphatides, and 2% Silicone (SE-52)
coated on 80—120 mesh Chromosorb G was used for the fatty
acids of the neutral sphirigolipids. The flow rate was 30 ml of
double purified nitrogen per minute at an inlet pressure of
50 pounds/inch2. The column temperature of the DEGS column
was 180°C at the start; 10 min after injection we started a tem-
perature elevation of 2°C per minute up to £00°C at the end. The
column temperature of the SE-52 column was 220°C at the start.
Ten minutes after injection we started a temperature program of
2°C per minute up to 250°C at the end. The quantitative recoveries
from each column were determined with NIH fatty acid standards
or own standards, the latter are being mainly phospholipid fatty
acid esters from bull testis and whale or dolphin brains, which are
determined with threefold gas liquid rechromatography, iodine
number, infra red, ultra violet, and mass spectrometry.
Using these methods it was possible to identify fatty acid methyl
esters as C-20:2cu9, C-20:3o>6 and -ω9, C-22:2eo6 and -ω9,
C-22: 3ω6 and -ω9, C-22: 5ω3 and -ω6.
The quantitative results agreed with the stated composition data
with a relative error of less than 2 to 3% for major components
and less than 4 to 6% for minor peaks.
The gas liquid Chromatographie analysis of fatty acid methyl
esters of normal and pathological brains were done in the same
manner as described previously for normal brains (references
see (9)). Comparison of the results from the gas liquid Chromato-
graphie apparatuses, which were used, showed a very good
similiarity. The unique problematic difference between both
apparatuses, however, seems to be a slightly higher sensitivity of
the FID of the Perkin Elmer model 900 for polyenoic acids
ranging between 2 and 4% of the sum of p lyunsaturated com-
ponents of each individual glycerophosphatide fatty acid mixture
in the normal brains.
The individual esters were identified by comparison with internal
standards whenever feasible but recently only with the aid of a
diagram of log retention time and C-number which has been
described by ACKMAN et al. (16). In both sphingolipids of patho-
logical brains examined, however, we regularly found peaks
(xl—x!3) in the gas liquid Chromatographie analysis on the
SE-52 column which at first could not be identified in the diagram
of ACKMAN and which have been not found in fatty acids of
sphingolipids of normal brains. Using mass spectrometry it was
possible to identify the peaks χ 6 and χ 8 as polyenoic acids (17)
and x3 and χ 5 as contaminations of the silica gel used and χ 7
as a contamination of the filter papers (Schleicher & Sch ll
paper 5893 and 157 41/2) which have been extracted twice with
organic solvents before using. There contaminants have been
identified previously (18).
Results
The yield of fatty acid methyl esters obtained by hy-
drolysis or esterification lies at 35—42% fot the
sphingolipids, and for the 2 glycerophosphatides at
roughly 65^-72% of the lipids. Compared with the
total lipids, the content of methyl esters of the gly-
cerophosphatides in the grey matter is t.5 to 2 times as
high as in the areas rich in white substance (white
matter and medulla oblongata). Referring to the fresh
weight, however, the highest content of total fatty
acids was found in white matter and medulla (Tab; 1).
The amounts of methyl esters are less in the brains of
patients with alcohol-related liver cirrhosis than in the
normal brains. The decrease of fatty acids corresponds to
the diminished lipid content of the "hep togenic
degenerated" brains s opposed to the normal brains.
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Tab. 1
Fatty aeid methyl esters of cerebrosides, sphingomyelins, phosphatidyl cholines and phosphatidyl ethanolamines in /itnol/g fresh weight of brains
with alcohol-related hepatogenic degeneration




































Sum of fatty acid methyl esters
in brains from alcoholics (n = 6) 47.18 107.63 67.54 107.21
Sum of fatty acid methyl esters
in normal brains (n = 6) 68.12 133.68 103.02 155.62
Tab. 2
Unsubstituted fatty acid composition of sphingolipids of brains with alcohol-related hepatogenic degeneration
Mean values (n = 6) are weight percentages of total unsubstituted fatty acid methyl esters of cerebrosides and sphingomyelins. The following
components (acids and unidentified substances, e. g. χ7) were detected in small amounts (in general less than 1%): 14:1, 15:0, 15:1, 17:0, 17:1,













































































































































































































The unsubstituted fatty acids of the
cerebrosides (Tab. 2)
From dodecanoic acid to hexacosenic acid all saturated
and mono-unsaturated even and odd numbered acids
were present, but some only in traces. The main compo-
nents were those with 18 and 24 C-atoms. Palmitic,
penta- and hexacosanoic acid accounted for 3—9%,
depending on the region. Ια all regions of the brain
from alcoholics the concentration of stearic acid was
lower than in the normal brain (Tab. 3). Nevertheless,
the concentration of long chain acids (C-24 and C-26)
was higher, except in the grey matter. The portion of
acids with a chain length of up to 20 C-atoms amounted,
on the average, to only 20—30%.
The 2-hydroxy fat ty acids of the cerebrosides
(Tab. 4)
All the components with an even and odd numbered
chain between hydroxy-dodecanoic acid and hydroxy-
hexacosanoic acid were also found in this fraction.
Apart from the cerebronic and hydroxy-nervonic acids,
the components with 22, 23, 25 and 26 C-atoms were
present in the highest concentrations. The proportion
of acids with less than 20 C-atoms was 10% for the
gtey matter and 5% for the white matter (Tab. 5).
The f a t t y acids of sphingomyelins (Tab. 2)
30% of both stearic and nervonic acid were found in
the white matter and medulla oblongata, while in the
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2-Hydroxy fatty acid composition of the cerebrosides of brains with
alcohol-related hepatogenic degeneration
Mean values (n = 6) are weight percentages of total hydroxy fatty
acid methyl esters of cerebrosides. The following were detected in
small amounts (in general less than 1%): 14h:l, 15 h:0, 15h:l,
17h:0, 17h:l, I8h:l , 19h:0, 19h:l, 20h:l , 21 h:l, 22h:l.




















































































regions with predominant grey matter the stearic acid
showed a 3—6 times higher concentration than the
nervonic acid. The proportion of both these main
components also corresponded to the sum of the fatty
acid methyl esters with more than 21 C-atoms (Tab. 3) :
in the grey matter and cerebellum the amount of the
acids with more than 21 C-atoms was considerably
smaller (20—40%) than in the areas rich in white
substance, where it was roughly 60%. The differences
between these two groups are highly significant.
The fat ty acids of the phosphatidyl cholines
(Tab. 6):
The main components are palmitic and oleic acid
followed by stearic acid. Only in the white matter and
medulla oblongata did the proportion of oleic acid
exceed that of the palmitic acid. The content of polyenoic
acids in the 4 regions averaged 10% of which the
arachidonic acid was the most important.
The fat ty acids of the phosphatidyl ethanola-
mines (Tab. 6):
As with the phosphatidyl cholines the main com-
ponents of the phosphatidyl ethanolarnines were the
acids with 16 and ISC-atoms; there were significant
differences between the regions of grey mattef and the
cerebrum on one side and the areas of white matter and
the medulla oblongata on the other. In all 4 regions the
amount of polyenoic acids was approximately equal.
However, there were clear differences between the
brain parts in the distribution of the single components.
In the parts rich in grey matter, the arachidonic -acid
and docosahexaenoic acid prevailed, and in the regions
rich in white substance, docosatetraenoic acid was
predominant.
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Tab. 5
Mean values and standard deviation of the main components of cerebreside 2-hydroxy fatty acids






































































































Fatty acid composition of 2 glycerophosphatides of brains with alcohol-related hepatogenic degeneration
Mean values (n = 6) are weight percentages of total fatty acid methyl esters of each glycerophosphatide. The following (except polyene») were











































































































































































































































Normal variations with age
During the course of myelination and maturation
quantitative changes occur in the lipids, including the
fatty acids. In the sphingolipids the very long acids
increase (19—24). In the glycerophosphatides (5, 23,
25—28) and cholesterol esters (29, 30) the proportion
of palmitic acid increases, while in the phosphatidyl
ethanolamines oleic acid increases at the expense of
stearic acid. The relative proportion of the polyenoic
acids up to docosahexaenoic acid remains fairly constant
in the grey matter and thalamus (25, 28) and is reduced
in the white matter (5). It is known that during ageing
there is a discreet regression of fatty acids, especially
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of the components with more than 24 C-atoms in the
grey and white matter (9).
This slight drop of the very long acids in the physiolo-
gical ageing process is not significant and has not been
related to histological changes. A relative decrease of
the very long fatty acids and a relative increase of the
palmitic and stearic acid become significant only when
senile brain lesions show morphological differences
compared with normal brains (31).
Pathological variations
The process of the fatty acid diminution is accelerated
many times when pathological changes exist (32).
Simultaneously there is an intensified loss of the poly-
21*
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enoic acids (33—35). These changes in the lipid and
fatty acid pattern are assumed to be the signs of typical
degenerative demyelinization as described and discussed
elsewhere (32).
The fatty acids of neutral sphingoliplds
In brains that we examined of patients showing al-
cohol-toxic cirrhosis with neurological and mental
symptoms, the changes in the fatty acid samples cor-
relate partly with those described above. The decrease
of the cerebrosides in all 4 regions (3) and the glycero-
phosphatides in the regions rich in white substance
points to a degenerative process. The decrease of
nervonic and hydroxynervonic acid in the sphingo-
lipids of the grey matter and the decline of docosa-
hexaenoic, arachidonic and stearic acid with the simulta-
neous rise of palmitic acid in the phosphatidyl etha-
nolamines of the grey matter fits into this picture.
Other changes, however, in the fatty acid array differed
from those described as typical for degeneration.
In the unsubstituted fatty acids of the cerebrosides
there was no decrease in the very long components in
all 4 regions, but only a decline of the stearic acid. In
the grey matter the loss of stearic acid coincided with a
significant rise of oleic acid and, in the regions rich in
white substance, with a slight rise of nervonic acid.
Altogether the proportional increase of the fatty
acids with more than 21 C-atoms in the white matter
and medulla oblongata was comparable with that in
normal brains (Tab. 3).
Compared with normal brains, the hydroxy fatty acids
of the cerebrosides showed a small decrease of the
hydroxytetracosenic and an increase of the hydroxy-
hexacosenic acid (Tab. 5) in the 4 regions; no other
differences were demonstrated.
Also in all 4 areas the stearic acid of the sphirigomyelins
was diminished. In the regions rich in white substance,
however, the acids with 22, 23, 25 and 26 C-atoms
\vere slightly increased (column "C21_26x" Tab. 3).
In the "white" tissue a slight chain lengthening was
found, whereas the changes in the grey matter resembled
those found in degeneration (32, 36).
The fatty acids of the cerebrosides and sphingomyelins
show a similar pattern due to their similar synthesis and
precursors (37). The synthesis and oxidation appear to
proceed in parallel and result in a displacement of the
fatty acid pattern in the white matter and medulla
oblongata, compared to healthy brains.
The result would be lowering of the lipid content,
compared with normal brains, i. e. degeneration.
Secondly, it seems that with a possible UDP-hexose
deficiency (38) or an enzyme inhibition, the cerebrosides
"over-age" because of a lack of de-novo-synthesis;
this is seen in the increasing concentration of very long
acids in these sphingolipids.
The fatty acids of glycerophospbatides
In the phosphatidyl cholines the fatty acid pattern of
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of the normal brains. The only exception was the
palmitic acid, which was clearly lower in the grey
matter of the pathological brains.
The striking changes of the fatty acids in the phos-
phatidyl ethanolamines were of two kinds: firstly a
generalized decrease of the stearic acid and increase of
the palmitic acid was found. The decrease of the chain
length was one of the above mentioned features of
ontogenetic brain degeneration.
However, the changes of the polyenoic acid compo-
sition of the phosphoglycerides must be interpreted in
a different way. The typical decrease of the polyenes
(5, 33, 35) seen in the degeneration, could not be found
in the brains of alcoholics. On the contrary, in the white
matter and medulla oblongata the proportion of
docosatetraenoic and docosahexaenoic acid was clearly
higher than in the normal brains. The increase of the
sum of total polyenoic acids in the respective regions
can also clearly be seen (not demonstrated in a table).
Are the changes in the brain in alcohol abuse caused
directly by the influence of alcohol or through a meta-
bolite of ethanol? Or do the changes first appear as a
result of the pathological metabolism in alcohol-related
liver cirrhosis ?
Reasons for cerebral degeneration: alcohol or
liver damage?
Acute and chronic alcohol abuse result in a peripheral
lipolysis with hyperlipacidemia (39, 40) followed by
supersaturation of the liver with rising hepatic fatty
acid synthesis (41) and decrease of fatty acid oxidation
(42). The increased hepatic triglyceride synthesis from
the acids of the depot fat is accompanied by a diminished
insertion of the fatty acids into the phosphatides (43).
Furthermore, the lipoprotein lipase activity is diminished
by ethanol (44, 45) which can only result in a further
supply of alimentary fat to the liver. This is further
aggravated by any existing dietary lack of protein (46).
MARCINIAK et al. (48) found, after giving dogs about
100 g ethanol per day over a period of 10 weeks, a
significant elevation of glycerides in liver, heart and
serum and an insignificant increase of glycerides in the
brain. The glycerides were determined separately from
the glycerophosphatides. This was the only indication
known to us of experimentally created lipid changes in
the brain after alcohol consumption. However, we
never found a high concentration of glycerides in
normal or pathological brains.
In ethanol-related cirrhosis the total fatty acids in the
serum differ from those of healthy controls (47): There
is a slight rise in palmitoleic and oleic acid and a slight
decrease in linoleic and arachidonic acid. These changes
indicate a disturbed lipid metabolism, but according to
our observations have no influence on the fatty acid
composition in the brain.
We could not find any reference that the changes of
lipid and fatty acid composition in liver and adipose
tissue in patients with alcoholic liver cirrhosis do have
an immediate influence on the fatty acid composition
of the brain. In none of the brain regions examined we
could find an indication that, due to lipolysis, more
free fatty acids from the depots were reaching the
brain, and the phosphoglycerides in particular. This
would confirm the assumption of SPERRT et al. (49, 50)
that the transport of saturated fatty acids into adult
mammalian brain is restricted by the blood-brain-
barrier.
Ethanol can lead to the WERNICKE-KORSAKOFF syn-
drome when consumed over a long period of time or in
large amounts without the accompaniment of a liver
impairment. Acute alcohol intake causes a reduction of
the blood flow to the brain, a diminished cerebral
oxygen consumption and glucose turn-over (51) and a
diminution of the glycogen content in the brain (52),
probably as a result of increased liberation of cate-
cholamines from the adrenal medulla. These results
are correlated anatomically by a completely different
observation: in alcoholics the third ventricle of the
brain is significantly widened (53) and the young brain
seems to be especially affected. The echoencephalo-
graphicälly measured brain atrophy, possibly related
particularly to the cortex, is an anatomic sign of the
degeneration.
Is the lowered brain metabolism in the chronic drinker
the biochemical equivalent of cortical atrophy? A
possible answer is our observation that in patients with
alcoholic toxic cirrhosis the lipid and fatty acid con-
centration in the brain is significantly decreased.
However, in liver insufficiency there is a rise of arr-
monia, free phenol and their derivatives (54), methyl
guanidine and free fatty acids (55) in the serum. Today
less importance is given than previously to the high
NH3 in the blood (56, 57). Recently it has been proved
that at least in healthy persons, the brain (58) and
skeletal muscle (59) metabolize as much ammonia as
the liver.
The increase of the phenylcarbonic acids and the aro-
matic hydroxy acids in the blood which is characteristic
for liver insufficiency, can lead to an accumulation of
these in the brain (60), where they result in enzymatic
changes (61) concerned with oxidative phosphorylation
in the brain.
To summarize, it can be said that the cause of the
cerebral degeneration in the alcohol-related liver
cirrhosis is not clear. One thing, however, is certain:
up to the present there has not been any proof that
alterations in liver metabolism, as found in alcoholics,
were the only cause of ethanolic "hepatocerebral
degeneration". The direct toxic effects of alcohol may
have just as much importance.
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